What Was Considered Normal Blood Pressure in 1960?

In 1960, many doctors considered a systolic blood pressure of 160 or even 180 perfectly acceptable for a middle-aged or older adult. The widely used rule of thumb was “100 plus your age,” meaning a 60-year-old with a systolic reading of 160 would not raise an eyebrow. The threshold that the earliest large-scale studies used to define hypertension was 160/95 mmHg, and even readings above that line were often left untreated. Compared with today’s guidelines, which flag anything above 130/80 as elevated, the gap is striking and worth understanding.

The “100 Plus Your Age” Rule

For much of the early and mid-twentieth century, a simple formula guided clinical thinking about blood pressure: take the patient’s age and add 100, and the result was their expected systolic reading. A 50-year-old with a systolic pressure of 150? Normal. A 70-year-old at 170? Expected. The formula was never based on rigorous outcome data. It reflected a belief, common among physicians of the era, that rising blood pressure was a natural and even necessary part of getting older. The logic went something like this: as arteries stiffened with age, the heart had to push harder to keep blood flowing to the brain, kidneys, and other vital organs. Lowering that pressure, the thinking went, might actually starve those organs of blood.

This was not a fringe view. A widely cited medical text from 1946 captured the prevailing attitude, arguing that elevated blood pressure might be “a natural response to guarantee a more normal circulation to the heart, brain and kidneys” and warning that “overzealous attempts to lower the pressure may do no good and often do harm.” That perspective persisted well into the 1960s. The term “essential hypertension” itself reinforced the idea: the word “essential” was used not in the modern medical sense of “of unknown cause” but was widely interpreted as meaning the high pressure was essential to survival.

How the Framingham Study Started Changing Minds

The Framingham Heart Study, launched in 1948 in a small Massachusetts town, was the project that began dismantling the “high blood pressure is harmless” orthodoxy. Its first major findings on blood pressure appeared in 1957. Using a threshold of 160/95 mmHg to define hypertension, researchers found that people above that line had roughly a fourfold increase in the rate of coronary heart disease. Within a few more years, they also showed that stroke was a major consequence of high blood pressure.¹

These were population-level numbers, not anecdotes. The Framingham researchers tracked thousands of people over years, watching who had heart attacks and strokes and who did not. The data showed clearly that hypertension was not a benign companion to aging but a powerful driver of cardiovascular disease.² Still, the medical community was slow to act on what Framingham was showing. The threshold of 160/95 itself now looks alarmingly high, but at the time it was considered a reasonable dividing line, and readings below it were widely viewed as safe even if they would alarm a modern physician.

The Debate Over Whether Hypertension Was Even a Disease

Part of why the 1960s medical world was slow to treat high blood pressure was a genuine scientific disagreement about what hypertension actually was. Two prominent British researchers, George Pickering and Robert Platt, spent years locked in a public argument that shaped how a generation of doctors thought about blood pressure.

Pickering argued that blood pressure was a continuously distributed trait across the population, like height or weight. Most people clustered in the middle range, with fewer at the extremes, and there was no natural dividing line between “normal” and “abnormal.” In his view, the clinical habit of sorting patients into “hypertensive” and “normotensive” categories was artificial and misleading. Platt disagreed. He believed the highest blood pressure values in a population identified a distinct group of people who had a specific disease, potentially explained by particular genetic characteristics.³

Pickering eventually won the intellectual argument: blood pressure is indeed a continuous variable, and the risk of cardiovascular disease rises gradually with increasing pressure rather than jumping at a single cutoff. But the practical consequence of this debate during the 1960s was confusion. If there was no clear line between normal and abnormal, how could a doctor decide when to intervene? And if high blood pressure in older people was just part of a normal bell curve shifting upward with age, was treatment even appropriate? Many physicians answered “no” and left their patients untreated.

FDR and the Cost of Doing Nothing

One of the starkest illustrations of mid-century attitudes toward blood pressure is the case of Franklin Delano Roosevelt. The president’s blood pressure climbed steadily throughout his time in office, eventually reaching severely elevated levels. His personal physician largely dismissed the readings, and Roosevelt received minimal treatment. He died of a cerebrovascular accident, a stroke caused by uncontrolled hypertension, in April 1945.⁴

Roosevelt’s case is often cited as a turning point, though change came slowly. If the sitting president of the United States could die from a condition his own doctor did not take seriously, the gap between what was known about blood pressure and what was done about it was enormous. By the early 1960s, this gap had barely narrowed. There were few effective medications, and the ones that existed often produced side effects so severe that patients felt worse on treatment than off it.

Why Doctors Were Reluctant to Treat

Throughout the 1960s, the medical community remained deeply divided over whether ordinary hypertension needed treatment at all. The available drugs were crude by modern standards. Early antihypertensives could cause fainting, depression, sexual dysfunction, and severe drops in blood pressure upon standing. For a patient whose only symptom was a high reading on a mercury gauge, the cure genuinely seemed worse than the disease.

The term “essential hypertension” compounded the problem. Because the elevated pressure was thought by many to be an unavoidable and perhaps even necessary part of aging, treatment felt counterintuitive. Physicians worried that lowering blood pressure in an older patient might reduce blood flow to the brain and kidneys, causing the very problems they were trying to prevent. The result was a widespread clinical attitude of watchful inaction: monitor the numbers, maybe recommend rest and a low-salt diet, but avoid drugs unless the situation became dire.

The Diastolic Fixation

When 1960s-era doctors did worry about blood pressure, they worried almost exclusively about the bottom number. Diastolic pressure, the reading taken when the heart is resting between beats, was considered the meaningful indicator of risk. Systolic pressure, the top number measured during heart contraction, was widely regarded as a noisy, unreliable signal that rose inevitably with aging and was not especially dangerous on its own.

This diastolic fixation shaped clinical trials and treatment decisions for decades. The choice to use diastolic blood pressure as the basis for deciding who needed medication was driven largely by the design of the earliest treatment trials, which selected patients based on diastolic readings.⁵ A patient with a systolic reading of 175 but a diastolic of 85 might have been told everything was fine, especially if they were over 60. Later research showed this was a serious mistake. Overreliance on diastolic blood pressure in evaluating cardiovascular risk turns out to be misleading, particularly in older adults whose systolic pressure may be climbing while diastolic pressure holds steady or even drops.⁶

Isolated systolic hypertension, the condition where the top number is high but the bottom number is not, is now recognized as a major cardiovascular risk factor. In 1960, it was largely dismissed.

The VA Trial That Rewrote the Rules

The moment that definitively proved high blood pressure should be treated came from a Veterans Administration cooperative study that ran through the late 1960s. The trial enrolled men with significantly elevated diastolic blood pressure and randomly assigned them to receive either a combination of drugs (thiazide diuretics and reserpine) or a placebo. The results were so dramatic that the trial was stopped early for the most severely affected group because withholding treatment had become ethically untenable.

Over five years, the risk of a serious cardiovascular event dropped from about 55% in the untreated group to 18% in the treated group. Deaths fell from 35 among untreated patients to 9 among those on medication. Twenty untreated patients developed dangerously severe hypertension with diastolic pressures of 125 mmHg or higher; none of the treated patients did. Treatment proved especially effective at preventing heart failure and stroke, though it was less protective against coronary events.⁷

The 1967 and 1970 publications from this trial confirmed the value of lowering blood pressure in adults with high diastolic readings and provided the push toward developing formal clinical guidelines. The first national blood pressure guideline did not appear until 1977, though, meaning that for a full decade after proof existed, no standardized recommendations told physicians what to do.⁸

How Today’s Numbers Compare

The distance between 1960s standards and current guidelines is not subtle. Under the most recent American College of Cardiology and American Heart Association guidelines, published in 2017, stage 1 hypertension starts at a systolic reading of 130 mmHg or a diastolic of 80 mmHg. Stage 2 hypertension begins at 140/90.⁹ Under the old 1960s framework, a reading of 160/95 was merely the starting point for concern, and many patients with readings well above that went untreated.

To put this concretely: a 55-year-old in 1960 with a blood pressure of 150/92 would have been told they were perfectly healthy by most physicians. That same reading today would place them squarely in stage 2 hypertension and would prompt a conversation about lifestyle changes and likely medication. Meanwhile, the “100 plus your age” formula would have given that 55-year-old a “normal” systolic target of 155, a number that now qualifies as well into the hypertensive range at any age.

The shift has not been universally smooth. Each time guidelines have lowered the threshold, debate has erupted over whether the new numbers are too aggressive, whether the harms of treatment at milder levels of hypertension outweigh the benefits, and whether pharmaceutical industry influence plays a role in expanding the definition of disease. These are legitimate arguments. But the overall trajectory of evidence across decades has consistently pointed in the same direction: lower is generally better, and the old thresholds were far too permissive.

Why Organ Damage Starts Earlier Than the Old Thresholds Suggested

One reason today’s thresholds are lower is the growing understanding that blood pressure does not have to be dramatically elevated to cause harm. Hypertension damages the heart, kidneys, and blood vessels gradually, often without symptoms.¹⁰ By the time a patient in 1960 reached the 160/95 threshold and was considered hypertensive, years of vascular damage had already accumulated.

Research has shown that even mild kidney dysfunction in people with hypertension is linked to early signs of cardiovascular trouble. In one study, after accounting for how long patients had been hypertensive and other risk factors, each incremental decline in kidney function was associated with a roughly 43% increase in the likelihood of thickening of the heart muscle or plaque buildup in the carotid arteries.¹¹ This kind of subclinical damage, organ injury that a patient cannot feel, was invisible to 1960s medicine not because it was absent but because nobody was looking for it at those blood pressure levels.

Blood Pressure Does Not Have to Rise With Age

Perhaps the most powerful argument against the old “100 plus your age” thinking comes from populations that live outside industrialized food systems. Researchers studying the Yanomami, an indigenous group in the Amazon rainforest with minimal contact with the modern world, found something remarkable: their blood pressure does not increase with age at all. The average rise in systolic pressure per year of age was essentially zero. By contrast, the neighboring Yekwana people, who have adopted more aspects of a market economy and a Western-influenced diet, showed a gradual rise of about 0.25 mmHg per year. Both groups started out with similar blood pressure in childhood, but by middle age the Yekwana had measurably higher readings.¹²

The Yanomami findings undercut the foundational assumption of mid-century medicine: that blood pressure must rise with age and that higher readings in older people are simply the body doing what it needs to do. Instead, the evidence suggests that the age-related blood pressure increases seen in industrialized countries are driven by diet, lifestyle, and environment. The “essential” in essential hypertension was never essential at all. It was a product of how most people in modern societies live, eat, and move. A doctor in 1960 looking at a 65-year-old patient with a systolic reading of 165 and declaring it normal was not observing an inevitable physiological truth. They were observing the downstream effects of salt intake, sedentary habits, and processed food, mistaking the consequences of modern life for a law of biology.

Measuring Blood Pressure in the Mid-Twentieth Century

It is worth noting that blood pressure measurement itself was less standardized in 1960 than it is today. The mercury sphygmomanometer was the instrument of the era, and readings depended heavily on the clinician’s ear and technique. There was no automated device to remove human error from the process. The oscillometric method, which eventually enabled the electronic monitors used in clinics and homes today, was not systematically described until the late 1960s and early 1970s, when researchers showed that specific points on the oscillation pattern corresponded to systolic and diastolic pressure.¹³

This measurement variability compounded the clinical uncertainty of the period. A single office reading taken by a busy doctor using a manual cuff was subject to white-coat effects, cuff-size mismatches, and listener bias. The modern emphasis on averaged readings from multiple visits, ambulatory monitoring, and validated automated devices did not exist. So not only were the thresholds for concern much higher, but the measurements themselves were less reliable. A patient in 1960 might have had their blood pressure checked once during an annual visit, recorded as 158/94, and heard their doctor say everything looked fine. Today that same patient would be flagged, retested on multiple occasions, and likely started on treatment if the readings held up.